Drugmaker Indivior Plc clinched a US contract worth up to $111 million for its opioid antidote—part of the government’s preparation for a potential bioterrorism attack with drugs such as fentanyl that can be released into the air. The contract will secure US supplies of Opvee, an opioid reversal medication that…